Schrödinger (SDGR) Stock Analysis & Winston Score
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical
Winston Score: 27/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Weak (6/30)
- Growth: Mixed (5/20)
- Cash Flow: Weak (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $15.32
Market Cap: $1.1B
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Exchange: NASDAQ
